¼¼°èÀÇ ±«»ç¼º ¸®Æ÷À̵åÄ«(NL) ½ÃÀå º¸°í¼­(2025³â)
Necrobiosis Lipodica (NL) Global Market Report 2025
»óǰÄÚµå : 1730958
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ±«»ç¼º ¸®Æ÷À̵åÄ« ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 6.7%·Î 56¾ï 5,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº °í·ÉÈ­ Àα¸ Áõ°¡, ÇǺΠ°Ç°­°ú ¹Ì¿ë¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÇǺÎÀÇ °Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ »ó½Â µîÀÇ ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Ä¡·á ¼±ÅÃÀÇ Áøº¸, Áø´Ü ±â¼úÀÇ Çâ»ó, »ý¹° Á¦Á¦ÀÇ Ã¤¿ë, ÀÓ»ó °Ë»çÀÇ ÁøÀü, Àç»ý ¿ä¹ýÀÇ ÃâÇö µîÀÌ ÀÖ½À´Ï´Ù.

´ç´¢º´ÀÇ ÀÌȯÀ² Áõ°¡´Â ÇâÈÄ ¸®Æ÷ÀÌµå ±«»çÁõ(NL) ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ç´¢º´Àº Àν¶¸° ºÐºñ ºÎÁ·°ú Àν¶¸° ÀúÇ×¼ºÀ¸·Î ÀÎÇØ ½Åü°¡ Ç÷´ç Á¶Àý¿¡ ¾î·Á¿òÀ» °Þ´Â ¸¸¼º ÁúȯÀ¸·Î ´Ù¾çÇÑ °Ç°­ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ç´¢º´ ȯÀÚ Áõ°¡´Â ¾É±â ½¬¿î ¶óÀÌÇÁ ½ºÅ¸ÀÏ, ½Ä»ýȰÀÇ È¥¶õ, À¯ÀüÀû ¼ÒÀο¡ ÀÇÇÑ Á¡ÀÌ Å®´Ï´Ù. ½Åü Ȱµ¿ÀÇ ÀúÇÏ, °úµµÇÑ ½ºÅ©¸° ŸÀÓ µîÀ» Ư¡À¸·Î ÇÏ´Â Çö´ëÀÇ ¶óÀÌÇÁ ½ºÅ¸ÀÏÀº ºñ¸¸°ú Àν¶¸° ÀúÇ×¼ºÀ» Á¶ÀåÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´À¸·Î Ç÷´çÀÌ ³ô¾ÆÁö¸é, °¡´Â Ç÷°ü¿¡ Àå¾Ö°¡ ÀϾ(¹Ì¼ÒÇ÷°üÁõ), Ç÷Çà ºÒ·®, »ê¼ÒÀÇ °¨¼Ò, ÇǺο¡ÀÇ ¿µ¾ç °ø±ÞÀÇ ÀúÇϸ¦ ÃÊ·¡ÇÕ´Ï´Ù. ±× °á°ú ÇǺΰ¡ ºÎ»óÀ» ÀԱ⠽±°í Ä¡À¯°¡ Áö¿¬µË´Ï´Ù. ±× °á°ú ÇǺΠÁ¶Á÷ÀÌ º¯¼ºµÇ¾î NL¿¡ ³ë¶õ»ö À§ÃàÀÌ Çü¼ºµË´Ï´Ù. 2023³â 10¿ù ±¹¹Îº¸°Ç¼­ºñ½º(National Health Service)ÀÇ º¸°í¿¡ µû¸£¸é À×±Û·£µå¿¡¼­ 1Çü ´ç´¢º´ÀÇ À¯º´·üÀº 2021³â 26¸¸ 1,710°Ç¿¡¼­ 2022³â 27¸¸ 935°ÇÀ¸·Î Áõ°¡ÇÏ¿© Àü³â´ëºñ 3.5% Áõ°¡Çß½À´Ï´Ù. µû¶ó¼­ ´ç´¢º´ ȯÀÚ ¼ö Áõ°¡´Â ±«»ç¼º ¸®Æ÷À̵åÄ« ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀÚ°¡¸é¿ª ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â ¶ÇÇÑ ±«»ç¼º ¸®Æ÷À̵åÄ« ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2024³â 11¿ù¿¡ Versorgungsatlas°¡ ¹ßÇ¥ÇÑ ¹Ù¿¡ µû¸£¸é µ¶ÀÏÀÇ ÇǺ¸ÇèÀÚ 7,324¸¸ 1,305¸í Áß, 2022³â¿¡´Â 630¸¸ 4,340¸íÀÌ Àû¾îµµ ÇϳªÀÇ ÀÚ°¡¸é¿ªÁúȯÀ¸·Î Áø´ÜµÇ¾úÀ¸¸ç, À¯º´·üÀº 8.61%¿´½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Necrobiosis lipoidica is a rare, chronic skin condition marked by yellowish, atrophic plaques with prominent blood vessels, most often appearing on the shins. It is associated with collagen degeneration, inflammation, and lipid accumulation within the skin.

The primary treatment options for necrobiosis lipoidica (NL) include therapies, medications, and other interventions. Therapy refers to treatments aimed at alleviating or healing the condition, often incorporating medical, psychological, or physical approaches. These treatments can be administered through various routes, including oral, topical, parenteral, and other methods. The diagnosis of NL is typically made using techniques such as skin biopsy, histopathology, and other diagnostic procedures. Treatments are distributed via channels such as hospital pharmacies, online pharmacies, and retail pharmacies. Additionally, the end users of these treatments include hospitals, home care settings, specialty clinics, and other healthcare providers.

The necrobiosis lipoidica (NL) market research report is one of a series of new reports from The Business Research Company that provides necrobiosis lipoidica (NL) market statistics, including the necrobiosis lipoidica (NL) industry global market size, regional shares, competitors with the necrobiosis lipoidica (NL) market share, detailed necrobiosis lipoidica (NL) market segments, market trends, and opportunities, and any further data you may need to thrive in the necrobiosis lipoidica (NL) industry. This necrobiosis lipoidica (NL) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The necrobiosis lipoidica market size has grown strongly in recent years. It will grow from $4.08 billion in 2024 to $4.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historical period can be attributed to factors such as the rising number of diabetes cases, the increasing prevalence of skin infections, higher healthcare spending, a growing incidence of cancer, and greater awareness of the disease.

The necrobiosis lipoidica market size is expected to see strong growth in the next few years. It will grow to $5.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The projected growth for the forecast period is driven by factors such as the increasing aging population, rising awareness of skin health and aesthetics, higher disposable incomes, growing awareness of skin health, and the rise of government initiatives. Key trends expected during this period include advancements in treatment options, improvements in diagnostic techniques, the adoption of biologics, progress in clinical trials, and the emergence of regenerative therapies.

The rising incidence of diabetes is expected to drive the growth of the necrobiosis lipoidica (NL) market in the future. Diabetes is a chronic condition where the body struggles to regulate blood sugar due to insufficient insulin production or insulin resistance, which can lead to various health complications. The increase in diabetes cases is largely attributed to sedentary lifestyles, poor diets, and genetic predisposition. Modern lifestyles, characterized by prolonged sitting, reduced physical activity, and excessive screen time, contribute to obesity and insulin resistance. High blood sugar levels in diabetes cause damage to small blood vessels (microangiopathy), which leads to poor circulation, reduced oxygen, and nutrient supply to the skin. This makes the skin more vulnerable to injury and delayed healing. As a result, skin tissue degenerates, contributing to the formation of yellowish, atrophic plaques in NL. For example, in October 2023, the National Health Service reported that the prevalence of Type 1 diabetes in England rose from 261,710 cases in 2021 to 270,935 cases in 2022, marking a 3.5% increase year-over-year. Therefore, the growing number of diabetes cases is fueling the growth of the necrobiosis lipoidica market.

The increasing incidence of autoimmune diseases is also expected to drive the growth of the necrobiosis lipoidica market. Autoimmune diseases occur when the body's immune system mistakenly attacks its own healthy cells and tissues. The rise in autoimmune diseases is influenced by factors such as genetic predisposition, environmental triggers, and lifestyle changes that affect immune system behavior. These diseases contribute to NL by causing chronic inflammation and immune dysfunction, which leads to collagen degeneration and impaired skin healing. For instance, in November 2024, Versorgungsatlas reported that, among 73,241,305 insured individuals in Germany, 6,304,340 were diagnosed with at least one autoimmune disease in 2022, resulting in a raw prevalence rate of 8.61%. This rising incidence of autoimmune diseases is driving the growth of the necrobiosis lipoidica market.

Leading companies in the necrobiosis lipoidica market are focusing on innovative solutions, such as developing websites for patient education, to enhance diagnosis, treatment accessibility, and disease management. Websites are digital platforms that provide information, services, or interactive features accessible via the internet. For example, in August 2022, Processa Pharmaceuticals, a US-based clinical-stage biopharmaceutical company, launched Necrobiosislipoidicastudy.com, a website designed to raise awareness about ulcerative necrobiosis lipoidica (uNL), a rare dermatological condition. The platform provides information on the ongoing Phase 2 clinical trial evaluating PCS499 as a potential treatment for uNL, furthering the company's commitment to advancing innovative therapies for underserved patient populations.

Major players in the necrobiosis lipodica (nl) market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Bausch Health Companies Inc., Galderma Laboratories L.P., Dr. Reddy's Laboratories Ltd., Incyte Pharmaceuticals, Celltrion Healthcare Co. Ltd., Almirall S.A., Samsung Bioepis Co. Ltd., Hovione, Momenta Pharmaceuticals Inc., HanAll Biopharma Co. Ltd., Processa Pharmaceuticals.

North America was the largest region in the necrobiosis lipoidica market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in necrobiosis lipoidica (NL) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the necrobiosis lipoidica (NL) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The necrobiosis lipoidica (NL) market consists of revenues earned by entities by provide services such as dermatology consultation, wound care services, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The necrobiosis lipoidica market includes sales of corticosteroids, immunomodulators, corticosteroid creams, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Necrobiosis Lipodica (NL) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on necrobiosis lipodica (nl) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for necrobiosis lipodica (nl) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The necrobiosis lipodica (nl) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Necrobiosis Lipodica (NL) Market Characteristics

3. Necrobiosis Lipodica (NL) Market Trends And Strategies

4. Necrobiosis Lipodica (NL) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Necrobiosis Lipodica (NL) Growth Analysis And Strategic Analysis Framework

6. Necrobiosis Lipodica (NL) Market Segmentation

7. Necrobiosis Lipodica (NL) Market Regional And Country Analysis

8. Asia-Pacific Necrobiosis Lipodica (NL) Market

9. China Necrobiosis Lipodica (NL) Market

10. India Necrobiosis Lipodica (NL) Market

11. Japan Necrobiosis Lipodica (NL) Market

12. Australia Necrobiosis Lipodica (NL) Market

13. Indonesia Necrobiosis Lipodica (NL) Market

14. South Korea Necrobiosis Lipodica (NL) Market

15. Western Europe Necrobiosis Lipodica (NL) Market

16. UK Necrobiosis Lipodica (NL) Market

17. Germany Necrobiosis Lipodica (NL) Market

18. France Necrobiosis Lipodica (NL) Market

19. Italy Necrobiosis Lipodica (NL) Market

20. Spain Necrobiosis Lipodica (NL) Market

21. Eastern Europe Necrobiosis Lipodica (NL) Market

22. Russia Necrobiosis Lipodica (NL) Market

23. North America Necrobiosis Lipodica (NL) Market

24. USA Necrobiosis Lipodica (NL) Market

25. Canada Necrobiosis Lipodica (NL) Market

26. South America Necrobiosis Lipodica (NL) Market

27. Brazil Necrobiosis Lipodica (NL) Market

28. Middle East Necrobiosis Lipodica (NL) Market

29. Africa Necrobiosis Lipodica (NL) Market

30. Necrobiosis Lipodica (NL) Market Competitive Landscape And Company Profiles

31. Necrobiosis Lipodica (NL) Market Other Major And Innovative Companies

32. Global Necrobiosis Lipodica (NL) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Necrobiosis Lipodica (NL) Market

34. Recent Developments In The Necrobiosis Lipodica (NL) Market

35. Necrobiosis Lipodica (NL) Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â